Akebia Therapeutics, Inc. (AKBA)
NCM – Real Time Price. Currency in USD
0.88
+0.01 (1.22%)
Market open: Aug 12, 2026, 1:42 PM EDT
0.87
+0.00 (0.40%)
Previous after-hours: Aug 11, 2026, 7:49 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
0.88
+0.01 (1.22%)
Market open: Aug 12, 2026, 1:42 PM EDT
0.87
+0.00 (0.40%)
Previous after-hours: Aug 11, 2026, 7:49 PM EDT
No Data
There are no news for this stock.
Total debt $210.8M significantly exceeds cash reserves ($157.3M), raising financial stability concerns
Total current assets $229.6M exceed Total current liabilities $160.9M, highlighting excellent liquidity
Debt-to-equity ratio (8.4) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-1.4x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $2.4M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.43 | 2.52 | 7.0 | |
| Quick ratio | 1.35 | 1.78 | 7.0 | |
| Debt to Equity | 8.43 | -0.80 | 2.0 | |
| Debt to Assets | 0.60 | 0.73 | 4.0 | |
| Interest coverage | -1.43 | -13.90 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 292M | 195M | 160M | 236M | 219M |
| Gross Profit | 205M | 119M | 91M | 195M | 173M |
| Operating Income | -65M | -46M | -50M | 23M | -13M |
| Net Income | -94M | -52M | -69M | -5M | -30M |
| EBITDA | -30M | -4M | -9M | 25M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -15.31 | N/A | 1.0 |
| Next quarter | -5.9 | 60 | 5.5 |
| Current year | -12.36 | -540 | 1.0 |
| Next year | -23.12 | -90.62 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -8.24 | 1.61 | 0 | 111.5 | 3.8 |
| Y/Y | -21.35 | -3706.47 | 999 | -88.98 | 3.3 |
| 3y average | -1.22 | 34.51 | 40.4 | 86.81 | 7.8 |
| 5y average | 1.24 | 39.31 | 45.96 | 40.59 | 8.3 |
| Weighted average score | 5.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |